Overview

Postsurgical Bupivacaine Extended-release Liposome Injection for Open-reduction Internal Distal Radius Fixation.

Status:
Terminated

Trial end date:
2016-08-01

Target enrollment:

Participant gender:

Summary

For patients undergoing open-reduction internal-fixaton (ORIF) of isolated distal radius fractures, administration of 66.5 mg of liposomal bupivacaine to operative field may decrease the need for post-operative narcotic pain medication.

Phase:

Phase 4

Details

Lead Sponsor:

University of Louisville

Treatments:

Bupivacaine